A monoclonal antibody raised against bacterially expressed MPV17 sequences shows peroxisomal, endosomal and lysosomal

Hans Weiher1,2, Haymo Pircher3, Pidder Jansen-Dürr4

  • 1Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, Martinistrasse 52, 20251, Hamburg, Germany. hans.weiher@fh-brs.de.

BMC Research Notes
|February 28, 2016
PubMed

Insights

Recessive mutations in the MPV17 gene cause fatal infantile liver disease. New research shows the MPV17 protein localizes to peroxisomes, endosomes, and lysosomes, not mitochondria, revealing a novel link to mitochondrial DNA depletion.

Area of Science:

  • Cell Biology
  • Genetics
  • Molecular Biology

Background:

  • Recessive MPV17 gene mutations cause fatal infantile mitochondrial DNA depletion syndrome.
  • MPV17 protein's cellular localization has been contradictory, reported in both peroxisomes and mitochondria.

Purpose of the Study:

  • To resolve the contradictory localization of the MPV17 protein.
  • To investigate the function of MPV17 in relation to mitochondrial DNA depletion.

Main Methods:

  • Generated and utilized two new mouse monoclonal antibodies against human MPV17.
  • Performed Western blots and immunohistochemistry on human U2OS cells.
  • Conducted immunofluorescence studies to assess co-localization with various cellular markers.

Main Results:

  • A specific monoclonal antibody recognized a 20 kD protein absent in MPV17-negative cells.
  • Immunofluorescence revealed MPV17 co-localizes with peroxisomal, endosomal, and lysosomal markers.
  • MPV17 did not co-localize with mitochondrial markers.

Conclusions:

  • The MPV17 protein is localized to peroxisomes, endosomes, and lysosomes, not mitochondria.
  • This finding suggests a novel connection between peroxisomal/endosomal/lysosomal function and mitochondrial DNA depletion.